mBIOTA Clinical Research Featured in Nutrients Review of SIBO Nutritional Management

Overview

A 2025 narrative review published in the peer-reviewed journal Nutrients, titled Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review, examines the role of dietary strategies in the management of small intestinal bacterial overgrowth (SIBO), including elemental diets.

The review references mBIOTA's clinical trial, conducted at Cedars-Sinai, highlighting findings on elemental diet tolerability, protocol completion, and changes in gut microbial composition for patients with SIBO and intestinal methanogen overgrowth (IMO).

Key Findings

1. SIBO recurrence remains a challenge.

The review cites recurrence rates of up to 43% within 9 months of antibiotic treatment, emphasizing the importance of individualized nutritional strategies for ongoing management, including low fermentation eating, to support symptom management and long-term digestive health. 

2. Palatability is a key barrier to elemental diet adherence. 

While elemental diets have demonstrated promising results in SIBO management, historically poor taste and tolerability have limited their practical use. The review references an earlier elemental diet study in which 11% of participants discontinued the protocol due to intolerance, illustrating the importance of developing formulations that patients can more comfortably complete.

3. mBIOTA's clinical findings demonstrate promising outcomes with a palatable elemental diet. 

The review highlights mBIOTA's prospective clinical trial, in which 100% of participants completed the two-week exclusive elemental diet protocol, 73% achieved breath-test normalization, and 83% reported adequate global symptom relief. The study also identified significant changes in gut microbial composition, including reductions in Prevotella_9, Fusobacterium, and Methanobrevibacter smithii.

Why It Matters

The inclusion of mBIOTA's clinical research in this independent scientific review reflects growing academic interest in elemental nutrition as an approach to the dietary management of SIBO and IMO.

Importantly, the review highlights a longstanding challenge associated with elemental diets: completing the protocol. With 100% of participants completing the two-week regimen, mBIOTA's clinical findings suggest that improved palatability may help address this barrier while supporting meaningful clinical outcomes.

Together, these findings contribute to the expanding evidence base for elemental nutrition and reinforce the importance of developing medical foods that combine clinical effectiveness with a more manageable patient experience.